Clinical Trial Update: A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and biodistribution of a single intrathecal dose of INS1201 in ambulatory male Duchenne Muscular Dystrophy patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• INS1201

Snippet

Sponsor: Insmed Gene Therapy LLC | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: RECRUITING